Research programme: Pim kinase inhibitors - SelvitaAlternative Names: SEL24; SEL24 program; SEL24-1; SEL24-B489
Latest Information Update: 09 Jan 2017
At a glance
- Originator Selvita
- Class Small molecules
- Mechanism of Action Fms-like tyrosine kinase 3 inhibitors; Proto oncogene proteins c pim 1 inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Acute myeloid leukaemia; Lymphoma